Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
The American Journal of Tropical Medicine and Hygiene|January 10, 2003
The role of agricultural use of insecticides in resistance to pyrethroids in Anopheles gambiae s.l. in Burkina FasoAbdoulaye Diabate, Thierry Baldet, Fabrice Chandre, et al.
Virology Journal|November 27, 2024
A comprehensive seroepidemiology of dengue and chikungunya arboviruses in Iran, 2020-2023Seyed-Mahmood Seyed-Khorami, Ehsan Mostafavi, Sepideh Gerdooei, et al.
Parasites & Vectors|January 25, 2024
Kdr genotyping and the first report of V410L and V1016I kdr mutations in voltage-gated sodium channel gene in Aedes aegypti (Diptera: Culicidae) from IranAhmadali Enayati, Reza Valadan, Mahboobeh Bagherzadeh, et al.
Methods (San Diego, Calif.)|June 2, 2018
Fluorinated diglucose detergents for membrane-protein extractionGildas Nyame Mendendy Boussambe, Pierre Guillet, Florian Mahler, et al.
Therapeutic Drug Monitoring|April 22, 2006
Dose individualization of carboplatin after a 120-hour infusion schedule: higher dose intensity but fewer toxicitiesCédric Mercier, Joseph Ciccolini, Bertrand Pourroy, et al.
Plos One|August 27, 2015
FFCD-1004 Clinical Trial: Impact of Cytidine Deaminase Activity on Clinical Outcome in Gemcitabine-Monotherapy Treated PatientsCindy Serdjebi, Johan Gagnière, Jérôme Desramé, et al.
Trials|January 17, 2019
PREDOMOS study, impact of a social intervention program for socially isolated elderly cancer patients: update to the study protocol for a randomized controlled trialAnne-Laure Couderc, Emilie Nouguerède, Karine Baumstarck, et al.
Trials|April 14, 2017
PREDOMOS study, impact of a social intervention program for socially isolated elderly cancer patients: study protocol for a randomized controlled trialElodie Crétel-Durand, Emilie Nouguerède, Hervé Le Caer, et al.
The Lancet. Healthy Longevity|March 3, 2024
Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised, open-label, phase 3 trialJoël Guigay, Cécile Ortholan, Damien Vansteene, et al.
The Lancet. Healthy Longevity|May 17, 2024
Adapted EXTREME regimen in the first-line treatment of fit, older patients with recurrent or metastatic head and neck squamous cell carcinoma (ELAN-FIT): a multicentre, single-arm, phase 2 trialJoël Guigay, Hervé Le Caer, François-Régis Ferrand, et al.
Pageof 8